Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 30 Records) |
Query Trace: Hallucinations and APOE[original query] |
---|
ApoE polymorphisms in narcolepsy. BMC medical genetics 2001 2 (): 9. Gencik M, Dahmen N, Wieczorek S, Kasten M, Gencikova A, Epplen J |
Genetic variation analysis in parkinson disease patients with and without hallucinations: case-control study. Archives of neurology 2001 Feb 58 (2): 209-13. Goetz C G, Burke P F, Leurgans S, Berry-Kravis E, Blasucci L M, Raman R, Zhou |
Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease. Neurology 2002 Apr 58 (8): 1182-8. Scarmeas N, Brandt J, Albert M, Devanand D P, Marder K, Bell K, Ciappa A, Tycko B, Stern |
Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype. Dementia and geriatric cognitive disorders 2002 14 (4): 208-12. Gabryelewicz T, Religa D, Styczynska M, Peplonska B, Pfeffer A, Wasiak B, Luczywek E, Golebiowski M, Androsiuk W, Czyzewski K, Przekop I, Barcikowska |
Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene. Neuroscience letters 2004 Sep 368 (1): 33-6. Craig David, Hart Dominic J, Carson Robyn, McIlroy Stephen P, Passmore A Pet |
ApoE epsilon4 allele is associated with incidental hallucinations and delusions in patients with AD. Neurology 2004 Sep 63 (6): 1105-7. Chang J B, Wang P N, Chen W T, Liu C Y, Hong C J, Lin K N, Liu T Y, Chi C W, Liu H |
Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease. Acta neurologica Scandinavica 2006 Jan 113 (1): 14-7. Feldman B, Chapman J, Korczyn A |
Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease. Dementia and geriatric cognitive disorders 2006 21 (1): 33-9. Suh Guk-Hee, Jung Hee Yeon, Lee Chang Uk, Oh Byoung Hoon, Lee Sang-Kyu, Lee NamJin, Kim JaeHyun, Kee Baik Seok, Ko Daekwan, Kim Young-Hoon, Ju Young-Su, Hong InJa, Choi Sungku, |
The effect of the apolipoprotein E gene polymorphisms and haplotypes on behavioural and psychological symptoms in probable Alzheimer's disease. Journal of neurology, neurosurgery, and psychiatry 2007 Feb 78 (2): 123-6. Pritchard A L, Harris J, Pritchard C W, Coates J, Haque S, Holder R, Bentham P, Lendon C |
Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007 Jan 32 (1): 171-9. Zdanys Kristina F, Kleiman Timothy G, MacAvoy Martha G, Black Benjamin T, Rightmer Tracy E, Grey Monique, Garman Katherine S, Tampi Rajesh R, Gelernter Joel, van Dyck Christopher |
Delusion symptoms are associated with ApoE epsilon4 allelic variant at the early stage of Alzheimer's disease with late onset. European journal of neurology : the official journal of the European Federation of Neurological Societies 2006 Feb 13 (2): 176-82. Spalletta G, Bernardini S, Bellincampi L, Federici G, Trequattrini A, Caltagirone |
Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease. Dementia and geriatric cognitive disorders 2007 23 (1): 42-6. van der Flier Wiesje M, Staekenborg Salka, Pijnenburg Yolande A L, Gillissen Freek, Romkes Rolinka, Kok Astrid, Bouwman Femke H, Scheltens Phil |
Phenotypic associations of tau and ApoE in Parkinson's disease. Neuroscience letters 2007 Mar 414 (2): 141-4. Papapetropoulos Spiridon, Farrer Matthew J, Stone Jeremy T, Milkovic Nicole M, Ross Owen A, Calvo Linda, McQuorquodale Donald, Mash Deborah |
Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: the Cache County Study. International psychogeriatrics / IPA 2008 Jun 20 (3): 538-53. Treiber Katherine A, Lyketsos Constantine G, Corcoran Chris, Steinberg Martin, Norton Maria, Green Robert C, Rabins Peter, Stein David M, Welsh-Bohmer Kathleen A, Breitner John C S, Tschanz JoAnn |
The frequency of the TRPC4AP haplotype in Alzheimer's patients. Neuroscience letters 2009 Feb 450 (3): 344-6. Poduslo S E, Huang R, Huang |
Neuropsychiatric symptoms and the APOE genotype in Alzheimer's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2009 Jul . Del Prete M, Spaccavento S, Craca A, Fiore P, Angelelli P |
Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease. Ageing research reviews 2011 (1): 87-103. Panza Francesco, Frisardi Vincenza, Seripa Davide, D'Onofrio Grazia, Santamato Andrea, Masullo Carlo, Logroscino Giancarlo, Solfrizzi Vincenzo, Pilotto Alber |
Apolipoprotein E e4 status modifies the effects of sex hormones on neuropsychiatric symptoms of Alzheimer's disease. Dementia and geriatric cognitive disorders 2012 33 (1): 35-42. Xing Yi, Qin Wei, Li Fang, Jia Xiang-Fei, Jia Jianpi |
Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype. Behavioral and brain functions : BBF 2012 Dec 8 (1): 1. Christie D, Shofer J, Millard SP, Li E, Demichele-Sweet MA, Weamer EA, Kamboh MI, Lopez OL, Sweet RA, Tsuang D |
Association of apolipoprotein E e4 (ApoE e4) homozygosity with psychiatric behavioral symptoms. Journal of Alzheimer's disease : JAD 2012 28 (1): 25-32. Michels Andreas, Multhammer Manuel, Zintl Maria, Mendoza Maria Cristina, Klünemann Hans-Herma |
Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2013 Nov 21 (11): 1116-24. Peters M E, Rosenberg P B, Steinberg M, Norton M C, Welsh-Bohmer K A, Hayden K M, Breitner J, Tschanz J T, Lyketsos C G, |
Clinical and pathologic presentation in Parkinson's disease by apolipoprotein e4 allele status. Parkinsonism & related disorders 2014 May 20 (5): 503-7. Monsell Sarah E, Besser Lilah M, Heller Katherine B, Checkoway Harvey, Litvan Irene, Kukull Walter |
TREM2 p.R47H substitution is not associated with dementia with Lewy bodies. Neurology. Genetics 2016 Aug 2 (4): e85. Walton Ronald L, Soto-Ortolaza Alexandra I, Murray Melissa E, Lorenzo-Betancor Oswaldo, Ogaki Kotaro, Heckman Michael G, Rayaprolu Sruti, Rademakers Rosa, Ertekin-Taner Nilüfer, Uitti Ryan J, van Gerpen Jay A, Wszolek Zbigniew K, Smith Glenn E, Kantarci Kejal, Lowe Val J, Parisi Joseph E, Jones David T, Savica Rodolfo, Graff-Radford Jonathan, Knopman David S, Petersen Ronald C, Graff-Radford Neill R, Ferman Tanis J, Dickson Dennis W, Boeve Bradley F, Ross Owen A, Labbé Catheri |
Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease. Current Alzheimer research 2017 Aug . Qian Winnie, Fischer Corinne E, Schweizer Tom A, Munoz David |
Apolipoprotein E-?4 allele predicts escalation of psychotic symptoms in late adulthood. Schizophrenia research 2018 12 206 82-88. Jonas Katherine, Clouston Sean, Li Kaiqiao, Fochtmann Laura J, Lencz Todd, Malhotra Anil K, Cicero David, Perlman Greg, Bromet Evelyn J, Kotov Rom |
Gender differences in presentation of behavioral and psychological symptoms in Alzheimer's disease in Taiwan. Aging & mental health 2019 Mar 1-6. Hsieh Sun-Wung, Chen Chun-Hung, Huang Ling-Chun, Chang Yu-Han, Yang Yuan-H |
Genetic risk scores and hallucinations in patients with Parkinson disease. Neurology. Genetics 2020 8 6 (5): e492. Kusters Cynthia D J, Paul Kimberly C, Duarte Folle Aline, Keener Adrienne M, Bronstein Jeff M, Dobricic Valerija, Tysnes Ole-Bjørn, Bertram Lars, Alves Guido, Sinsheimer Janet S, Lill Christina M, Maple-Grødem Jodi, Ritz Beate |
Predictors of cognitive impairment in Parkinson's disease: a systematic review and meta-analysis of prospective cohort studies. Journal of neurology 2020 3 268 (8): 2713-2722. Guo Yu, Liu Feng-Tao, Hou Xiao-He, Li Jie-Qiong, Cao Xi-Peng, Tan Lan, Wang Jian, Yu Jin-T |
Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease.
![]() Molecular psychiatry 2021 Jun . DeMichele-Sweet Mary Ann A, Klei Lambertus, Creese Byron, Harwood Janet C, Weamer Elise A, McClain Lora, Sims Rebecca, Hernandez Isabel, Moreno-Grau Sonia, Tárraga Lluís, Boada Mercè, Alarcón-Martín Emilio, Valero Sergi, , Liu Yushi, Hooli Basavaraj, Aarsland Dag, Selbaek Geir, Bergh Sverre, Rongve Arvid, Saltvedt Ingvild, Skjellegrind Håvard K, Engdahl Bo, Stordal Eystein, Andreassen Ole A, Djurovic Srdjan, Athanasiu Lavinia, Seripa Davide, Borroni Barbara, Albani Diego, Forloni Gianluigi, Mecocci Patrizia, Serretti Alessandro, De Ronchi Diana, Politis Antonis, Williams Julie, Mayeux Richard, Foroud Tatiana, Ruiz Agustin, Ballard Clive, Holmans Peter, Lopez Oscar L, Kamboh M Ilyas, Devlin Bernie, Sweet Robert |
Role of Apolipoprotein E in the Clinical Profile of Atypical Parkinsonian Syndromes. Alzheimer disease and associated disorders 2022 1 36 (1): 36-43. Nasri Amina, Sghaier Ikram, Gharbi Alya, Mrabet Saloua, Ben Djebara Mouna, Gargouri Amina, Kacem Imen, Gouider Ria |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: